RecruitingNCT05316883
Biomarkers before and after clozapine for schizophrenia and related psychoses
About this title
Read the official source — NCT05316883Medication studyAges 18–64Denmark
Understand this study
Who could participate?
Listed age limits: 18 years to 64 years.
- Listed locations
- Glostrup MunicipalitySee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: February 28, 2021
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 200
- Sponsor
- Jimmi Nielsen
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- Denmark
- Age range
- From 18 Years to 64 Years
- Official registry ID
- NCT05316883
- Official title
Show the full official title
Biomarkers in Clozapine-responding Schizophrenia
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Glostrup Municipality
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Jimmi Nielsen.
Does this study involve medication?
Yes. The study involves medication, including Clozapine.
Who can participate?
Listed age limits: 18 years to 64 years.
Is this study still recruiting?
The registry lists this study as recruiting.
